HO-1197 treatment not only induced γ-H2AX foci formation [Figure 2E], a marker of DNA damage, but also increased γ-H2AX expression [Figure 2F] in a dose-dependent manner in HCC cells. Here, H2AX is linked to hepatocellular carcinoma.